View Website »

The NIH-funded Northeastern University Center for Translational Cancer Nanomedicine (CTCN) has been established in September 2010 as part of Phase 2 of the National Cancer Institute's Alliance for Nanotechnology in Cancer program with collaborations at Beth Israel Deaconess Hospital; Harvard Medical School; Tufts University, Auburn University, and Nemucore Medical Innovations, Inc. The CTCN will utilize the support and facilities of the NU-based Center for High-rate Nanomanufacturing.

Northeastern University CTCN is one of the only nine Centers of Cancer Nanotechnology Excellence (CCNE) across the country that has been awarded with a five-year, $13.5 million grant from the NCI Alliance in an open nationwide competition.